Dexmedetomidine Premedication in Hypertensive Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.

Also called NCT02058485

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 162 participants (enrolled count) (from the registry)
Sponsor
Duzce University (from the registry)
Registry
  • NCT NCT02058485
Other papers using this trial's data
  • Does premedication with dexmedetomidine provide perioperative hemodynamic stability in hypertensive patients? BMC anesthesiology, 2014 DOI, PubMed 25550680, PMC4279802 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02058485. Randomized; triple masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2013-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dexmedetomidine Premedication in Hypertensive Patients
Condition
Hypertension
Intervention (Drug)
Midazolam
Intervention (Drug)
Dexmedetomidine
Lead sponsor
Duzce University (class: other)

Record details

Record id
cardio:ct-nct02058485
Content hash
b655855a1ddf05b89f2b6b8626a13b38b7fbb66027bec54a0c9b7e2bf0c5bac0